Traumatic Brain Injury

Houston Methodist

M. E. Zwillman

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Treating KRAS-Mutated mCRC

Ibrahim Sahin

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Treating HER2-Amplified mCRC

Ibrahim Sahin

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

2024 ASCO® Annual Meeting Insights Hub

C. Eng

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Treatment of mCRC After Standard Chemotherapy

UChicago Medicine

A. Shergill

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

C. Jackson

ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Be…

Insights from 2024 ESMO GI Annual Meeting

Y. Sunakawa

ASCO®, ESMO, and NCCN Guidelines on Treatment and Biomarker Testing/…

Northwestern Medicine Oncology and Hematology

A. Benson

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

ESMO 2023 Summary: "Highlights From Recent GI Cancer Trials"

ecancer

B. Gyawali